Cargando…
Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A
Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494152/ https://www.ncbi.nlm.nih.gov/pubmed/34659972 http://dx.doi.org/10.7759/cureus.17760 |
_version_ | 1784579250779586560 |
---|---|
author | Jayasundara, Hishali D Herath, Lasitha Y Kularatne, Keertie S |
author_facet | Jayasundara, Hishali D Herath, Lasitha Y Kularatne, Keertie S |
author_sort | Jayasundara, Hishali D |
collection | PubMed |
description | Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of the antibody is the mainstay of treatment. Nontraumatic retrobulbar hemorrhage is a very rare presentation of hemophilia. We report an elderly male presenting with retrobulbar hemorrhage secondary to AHA who was successfully treated with immunosuppression. |
format | Online Article Text |
id | pubmed-8494152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-84941522021-10-14 Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A Jayasundara, Hishali D Herath, Lasitha Y Kularatne, Keertie S Cureus Dermatology Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of the antibody is the mainstay of treatment. Nontraumatic retrobulbar hemorrhage is a very rare presentation of hemophilia. We report an elderly male presenting with retrobulbar hemorrhage secondary to AHA who was successfully treated with immunosuppression. Cureus 2021-09-06 /pmc/articles/PMC8494152/ /pubmed/34659972 http://dx.doi.org/10.7759/cureus.17760 Text en Copyright © 2021, Jayasundara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Dermatology Jayasundara, Hishali D Herath, Lasitha Y Kularatne, Keertie S Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title | Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title_full | Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title_fullStr | Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title_full_unstemmed | Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title_short | Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A |
title_sort | retrobulbar hemorrhage secondary to acquired hemophilia a |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494152/ https://www.ncbi.nlm.nih.gov/pubmed/34659972 http://dx.doi.org/10.7759/cureus.17760 |
work_keys_str_mv | AT jayasundarahishalid retrobulbarhemorrhagesecondarytoacquiredhemophiliaa AT herathlasithay retrobulbarhemorrhagesecondarytoacquiredhemophiliaa AT kularatnekeerties retrobulbarhemorrhagesecondarytoacquiredhemophiliaa |